Latest News

Adyen (ENXTAM:ADYEN) has quietly drifted lower this year, and that slide is turning heads. With the stock down about 7% year to date, investors are rechecking what they are actually paying for. See our latest analysis for Adyen. The recent slide adds to what has been a choppy stretch, with a 30 day share price return of minus 5.7% and a 1 year total shareholder return near minus 10%, suggesting momentum is still fading despite solid underlying growth. If Adyen’s pullback has you reassessing...

If you are wondering whether Dynavax Technologies is quietly turning into a value opportunity or just another biotech rollercoaster, you are in the right place. The stock has slipped about 4% over the last week but is still up roughly 9.2% over the past month, even though it remains down around 15.0% year to date and 14.5% over the last year, after a strong 140.0% gain over five years. Recent attention has centered on Dynavax's expanding role in vaccine adjuvants and partnerships that aim to...

Uniper (XTRA:UN0) has quietly climbed about 16% over the past month, even as its one year return is still negative. That kind of rebound naturally raises questions about what has really changed. See our latest analysis for Uniper. Zooming out, that 15.5% one month share price return looks more like a short term reset after a tough stretch. The year to date share price is still notably negative and the five year total shareholder return is deeply underwater, suggesting momentum is only just...

If you are wondering whether Nutanix at around $47 a share is a bargain in disguise or a value trap waiting to happen, this breakdown is for you. The stock has slid about 33.3% over the last month and is down 22.6% year to date, yet it is still sitting on gains of roughly 57.4% over 3 years and 59.6% over 5 years. That kind of whiplash in returns has coincided with shifting sentiment around high growth software names, as investors rotate between riskier cloud stories and more predictable...

TETRA Technologies recently announced it signed a term sheet to form a joint venture with Magrathea Metals to integrate electrolytic magnesium production into its Evergreen Project in Southwest Arkansas, which is expected to produce 75 million pounds of bromine annually and recover other critical minerals like lithium and magnesium. This collaboration aims to help rebuild the U.S. magnesium metal defense industrial base using brine-based resources, potentially broadening TETRA’s role in...

If you are wondering whether Dutch Bros at around $61 a share is a caffeine fueled bargain or just pricey buzz, this article is for you. We are going to unpack what the current market price really implies about its future. The stock has quietly kept the momentum going, up about 5% over the last week, 12.3% over the past month, and roughly 12.9% over the last year, compounding into an 87.2% gain over three years. Behind those moves, Dutch Bros has been steadily expanding its store footprint...

The board of Headwater Exploration Inc. ( TSE:HWX ) has announced that it will pay a dividend of CA$0.11 per share on...

Key Insights Fonterra Co-operative Group will host its Annual General Meeting on 11th of December CEO Miles Hurrell's...

As the Canadian market navigates policy shifts and global uncertainties, it's important to recognize the strong equity gains that have emerged, with the TSX on track for its best year since 2009. In this context, identifying promising investment opportunities involves looking at companies that combine value with growth potential. Penny stocks, often smaller or newer firms, continue to be relevant in this search when backed by solid financials. Here, we explore three such stocks that stand out...

Wondering if Marriott International at around $306 a share is still a smart buy or if most of the upside is already priced in? You are not alone. This stock divides opinion among value focused investors. Over the last month the stock has climbed 12.6%, adding to a strong 3 year gain of 96.7% and a 5 year gain of 141.3%, while the 1 year return of 5.9% and 7 day move of 0.7% suggest momentum has cooled a little. Recently, investors have been digesting a mix of travel industry updates, from...

CureVac (NasdaqGM:CVAC) has just been dropped from the NASDAQ Biotechnology Index, a mechanical change that can still matter for investors as index tracking funds trim positions and liquidity dynamics start to shift. See our latest analysis for CureVac. That index removal lands after a busy stretch for CureVac, including new board appointments and mixed earnings. It also comes at a time when the share price has climbed sharply year to date, although longer term total shareholder returns still...

Aduro Clean Technologies recently entered a collaboration with Mexican non-profit ECOCE to assess the use of its Hydrochemolytic™ Technology for recycling flexible plastic packaging and mixed, multilayer plastics in Mexico. This partnership not only targets a difficult waste stream but also seeks to create new recycling business models and market opportunities for ECOCE members and other stakeholders. We’ll now explore how this focus on Hydrochemolytic™ recycling for flexible packaging could...

Global Ship Lease (NYSE:GSL) is leaning into its fleet renewal strategy by agreeing to buy three Korean built 8,600 TEU containerships with ECO upgrades and long term charters attached for $90 million. See our latest analysis for Global Ship Lease. That strategy is landing against a strong backdrop, with the share price up 14.4 percent over the past month and delivering a 73.6 percent total shareholder return over the last year. This suggests momentum is building as earnings and fleet moves...

Rheinmetall (XTRA:RHM) just paired strong sales growth with a record €64 billion order backlog, powered by fresh NATO and European ammunition deals. This puts its long term defence expansion plans firmly in the spotlight. See our latest analysis for Rheinmetall. Those blockbuster defence orders arrive after a sharp run up in the shares, with a year to date share price return of around 151%. However, the 3 month share price return is currently negative, while the 5 year total shareholder...

IDEXX Laboratories recently reported its third-quarter 2025 results, posting earnings per share of $3.40, a 21.4% increase year over year, and raised its full-year 2025 outlook for both revenue and earnings growth. The strong performance was powered by robust expansion in the Companion Animal Group and Livestock, Poultry and Dairy segments, highlighting the growing importance of recurring diagnostics and testing services in IDEXX’s global portfolio. With IDEXX lifting full-year guidance on...

In November 2025, Perrone Robotics filed patent infringement lawsuits in U.S. federal courts against seven automakers, including Toyota, alleging unauthorized use of its automated driving and robotics technologies in vehicle software and driver-assistance systems. The cases spotlight how foundational autonomous driving software patents can affect major manufacturers like Toyota, potentially influencing how they develop, license, or partner on future vehicle automation platforms. We’ll now...

Absci (ABSI) just crossed an important milestone by dosing the first healthy volunteers in its Phase 1/2a HeadLINE trial for ABS-201, an AI designed antibody targeting androgenetic alopecia and, later, endometriosis. See our latest analysis for Absci. The ABS-201 milestone lands after a volatile stretch, with the share price up 8.6 percent over one day and 6.5 percent over seven days, yet still showing a negative 30 day share price return while the 1 year total shareholder return remains...

If you are wondering whether Science Applications International is quietly turning into a value opportunity after a rough stretch in the market, you are not alone. This is exactly what we are going to unpack. The stock now trades around $87.53, up 2.1% over the last week but still down 4.2% over 30 days and 22.0% year to date, reflecting a market that has cooled on the name after a longer 1 year slide of 28.4%. In recent months, investor attention has been shaped more by shifting sentiment...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

As the Dow Jones and S&P 500 approach record highs, buoyed by expectations of a potential Federal Reserve rate cut, the U.S. tech sector remains a focal point for investors navigating an evolving economic landscape marked by mixed employment data and fluctuating Treasury yields. In such a dynamic environment, identifying high-growth tech stocks involves assessing factors like innovation potential, market positioning, and adaptability to macroeconomic shifts that can influence performance in...

As the Dow Jones and S&P 500 approach record highs, investors are closely watching market movements amidst expectations of a potential interest rate cut by the Federal Reserve. In this environment, identifying stocks that may be trading below their intrinsic value can offer opportunities for those seeking to capitalize on market inefficiencies.

As the Dow Jones and S&P 500 approach record highs, investors are keeping a close eye on market movements and potential interest rate cuts by the Federal Reserve. Investing in penny stocks—though a somewhat outdated term—remains relevant as these stocks often represent smaller or newer companies that can offer unique growth opportunities. By focusing on those with strong financials, investors may uncover hidden gems poised for long-term success amidst current market conditions.

You may think that with a price-to-sales (or "P/S") ratio of 9.6x Clearwater Analytics Holdings, Inc. ( NYSE:CWAN ) is...

In December 2025, Black Stone Minerals, L.P. announced it had entered into a multi-year development agreement with an affiliate of Caturus Energy, covering 220,000 gross acres in the Shelby Trough and Haynesville Expansion to support growing Gulf Coast natural gas demand. The deal outlines a structured ramp-up from pilot wells in the first two years to about 12 gross wells annually by year six, potentially unlocking more value from Black Stone’s roughly 40,000 undeveloped net acres in the...